CargoAdmin, Bureaucrats, Moderators (CommentStreams), fileuploaders, Interface administrators, newuser, Push subscription managers, Suppressors, Administrators
5,230
edits
Cancer Tissue Engineering Collaborative: Difference between revisions
Cancer Tissue Engineering Collaborative (view source)
Revision as of 09:34, 31 March 2025
, 31 Marchno edit summary
(Created page with "{{Organization |OrganizationName=Cancer Tissue Engineering Collaborative |OrganizationType=Research and Development Agencies |Mission=The Cancer Tissue Engineering Collaborative accelerates cancer research by supporting the development and characterization of biomimetic tissue-engineered technologies. It fosters multidisciplinary collaboration to create innovative in vitro and ex vivo models that mimic cancer pathophysiology for studying complex cancer phenomena. |Or...") |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Organization | {{Organization | ||
|OrganizationName=Cancer Tissue Engineering Collaborative | |OrganizationName=Cancer Tissue Engineering Collaborative | ||
|OrganizationType=Research and Development Agencies | |OrganizationType=Research and Development Agencies | ||
|Mission= | |Mission=Cancer Tissue Engineering Collaborative boosts research with biomimetic tech, fostering collaboration for innovative cancer models | ||
| | |ParentOrganization=National Cancer Institute | ||
| | |TopOrganization=National Institutes of Health | ||
| | |OrganizationExecutive=Program Director | ||
|Services=Tissue engineering research support; collaborative workshops; funding opportunities; model validation | |||
|Services=Tissue engineering research support; collaborative workshops; funding opportunities; model validation | |HeadquartersLocation=39.09808, -77.18917 | ||
|HeadquartersAddress=9609 Medical Center Drive, Rockville, MD 20850, USA | |||
|Website=https://www.cancer.gov/about-nci/organization/dcb/research-programs/tec | |||
}} | |||
'''Cancer Tissue Engineering Collaborative (TEC)''' is a research program within the National Cancer Institute (NCI), initiated in 2016 to advance cancer research through state-of-the-art tissue-engineered technologies, administered by NCI’s Division of Cancer Biology. Operating from NCI’s Shady Grove campus in Rockville, Maryland, TEC funds multidisciplinary projects integrating cancer biology with regenerative medicine, biomaterials, and bioengineering, supporting over a dozen research teams to develop 3D biomimetic models that replicate tumor microenvironments, with applications in understanding metastasis, drug response, and tumor progression. | |||
|HeadquartersLocation=39. | |||
|HeadquartersAddress=9609 Medical Center Drive, Rockville, MD 20850, USA | |||
}}'''Cancer Tissue Engineering Collaborative (TEC)''' is a research program within the National Cancer Institute (NCI), initiated in 2016 to advance cancer research through state-of-the-art tissue-engineered technologies, administered by NCI’s Division of Cancer Biology. Operating from NCI’s Shady Grove campus in Rockville, Maryland, TEC funds multidisciplinary projects integrating cancer biology with regenerative medicine, biomaterials, and bioengineering, supporting over a dozen research teams to develop 3D biomimetic models that replicate tumor microenvironments, with applications in understanding metastasis, drug response, and tumor progression. | |||
{{Official URL (simple)|url=https://www.cancer.gov/about-nci/organization/dcb/research-programs/tec}} | {{Official URL (simple)|url=https://www.cancer.gov/about-nci/organization/dcb/research-programs/tec}} | ||